Define Ventures
Define Ventures surveyed more than 40 executives from 15 of the top 20 pharma companies on the readiness of AI in healthcare, says Carolyn Magill, venture partner at the VC firm. A vast majority said AI is a priority in healthcare.
Lynne Chou O'Keefe, founder and managing partner of Define Ventures, tells MobiHealthNews what characteristics of a company are essential to garner investment.
The company is now valued at more than $1.6 billion.
The company has expanded to include more virtual care options after the coronavirus pandemic.
The new funding round was led by GV with participation from Bain Capital Ventures, Casdin Capital and Define Ventures.